Publication | Open Access

Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson’s disease and depression

PsychiatryAminergic AgentsMedicineNeurotransmitterMonoamine NeurotransmittersPsychopharmacologyNeuropharmacologyNovel Neuropsychiatric DrugsNeuroscienceBiological PsychiatryMood DisordersDrosophila Modifier ScreensDopaminePharmacologySocial Sciences